does semaglutide reduce insulin resistance Ozempic (semaglutide), a medication FDA-approved for type 2 diabetes and chronic weight management, is increasingly being discussed by people living with endometriosis. While not approved to treat the condition, we know that Trends in insulin resistance: insights

Improper storage and handling: Peptide-based injections typically require cold-chain storage

A small change in lean mass on a scan may be less concerning than a patient who reports: New falls or near-falls Progressive weakness Difficulty getting out of a chair Reduced walking tolerance Inability to perform usual daily activities Persistent dizziness or dehydration Severe appetite loss Inability to consume adequate nutrition Loss of training capacity Rapid, unplanned, or poorly tolerated weight loss These are not simply body-composition issues

Nat Commun 12 , 3763 (2021)

However, the body does not always lose fat evenly from every area

An extension phase (NCT06780449) will assess longer-term outcomes

Key Benefits: Powerful antioxidant and detoxifier